ArticleBlood advances2024

Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

Nathan Denlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.